ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 101 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2014. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 140,000 | $6,847,000 | 2.78% |
| WEATHERBIE CAPITAL, LLC | 337,788 | $16,521,000 | 2.34% |
| Opaleye Management Inc. | 65,000 | $3,179,000 | 2.12% |
| SPHERA FUNDS MANAGEMENT LTD. | 105,000 | $5,136,000 | 1.33% |
| Cormorant Asset Management, LP | 110,842 | $5,421,000 | 0.77% |
| Rock Springs Capital Management LP | 141,500 | $6,921,000 | 0.51% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 863,392 | $42,229,000 | 0.49% |
| ROCKEFELLER FINANCIAL SERVICES INC | 396,346 | $19,385,000 | 0.39% |
| Opus Point Partners Management, LLC | 7,074 | $346,000 | 0.33% |
| Eventide Asset Management | 87,400 | $4,275,000 | 0.26% |